Nutrition in cirrhosis and chronic liver disease

Clinics in Liver Disease

Volumn 18, Issue 1, 2014, Pages 179-190

  Juakiem, Wassem ^a   Torres, Dawn M ^b   Harrison, Stephen A ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Assessment; Chronic liver disease; Cirrhosis; Management; Nutrition

Indexed keywords

CALORIC INTAKE; CHRONIC LIVER DISEASE; DIETARY INTAKE; DIGESTIVE SYSTEM FUNCTION DISORDER; END STAGE LIVER DISEASE; GASTROINTESTINAL ABSORPTION; HUMAN; LIVER CIRRHOSIS; MALABSORPTION; MALNUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PREVALENCE; REVIEW;

ASSESSMENT; CHRONIC LIVER DISEASE; CIRRHOSIS; MANAGEMENT; NUTRITION;

AMINO ACIDS, BRANCHED-CHAIN; CHRONIC DISEASE; DIGESTION; HUMANS; INTESTINAL ABSORPTION; LIVER CIRRHOSIS; LIVER DISEASES; MALNUTRITION; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROBIOTICS;

EID: 84888043011     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2013.09.004     Document Type: Review

References (53)

1. Centers for Disease Control and Prevention (CDC) Death and hospitalizations from chronic liver disease and cirrhosis: Unites States 1980-1989. MMWR Morb Mortal Wkly Rep 1996, 41:969-973.
2. Asrani S.K., Larson J.J., Yawn B., et al. Underestimation of liver-related mortality in the United States. Gastroenterology 2013, 145:375-382.
3. Rehm J., Samokhvalov A.V., Shield K.D. Global burden of alcoholic liver diseases. JHepatol 2013, 59(1):160-168.
4. Carvalho L., Parise E.R. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006, 43(4):269-274.
5. Simon D., Galambos J.T. Arandomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. JHepatol 1988, 7:200.
6. Mezey E., Potter J.J., Rennie-Tankersley L., et al. Arandomized placebo controlled trial of vitamin E for alcoholic hepatitis. JHepatol 2004, 40:40.
7. Altamirano J., Higuera-de laTijera F., Duarte-Rojo A., et al. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis. Am J Gastroenterol 2011, 106:1472.
8. Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. JClin Gastroenterol 2011, 45:714.
9. Altamirano J., Fagundes C., Dominguez M., et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 2012, 10:65.
10. Sam J., Nguyen G.C. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int 2009, 29:1396-1402.
11. Alvares-da-Silva M.R., Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005, 21:113-117.
12. Cheung K., Lee S.S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012, 10:117.
13. Plauth M., Schütz E.T. Cachexia in liver cirrhosis. Int J Cardiol 2002, 85:83-87.
14. Grsberg A.J., Scarlett J.M., Marks D.L. Hypothalamic mechanisms in cachexia. Physiol Behav 2010, 100:478-489.
15. Kalaitzakis E., Bosaeus I., Ohman L., et al. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007, 85:808-815.
16. Aqel B.A., Scolapio J.S., Dickson R.C., et al. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005, 3:1095-1100.
17. Dudrick S.J., Kavic S.M. Hepatobiliary nutrition: history and future. JHepatobiliary Pancreat Surg 2002, 9:459-468.
18. Badley B.W., Murphy G.M., Boucheir I.A., et al. Diminished micellar phase lipid in patients with chronic non-alcoholic liver disease and steatorrhea. Gastroenterology 1970, 58:781-789.
19. Vlahcevic Z.R., Buhac I., Farrar J.T., et al. Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism. Gastroenterology 1971, 60(4):491.
20. Tsiaousi E.T., Hatzitolios A.I., Trygonis S.K., et al. Malnutrition in end of stage liver disease: recommendation and nutritional support. JGastroenterol Hepatol 2008, 23:527-533.
21. Charlton M. Alcoholic liver disease: energy and protein metabolism in alcoholic liver disease. Clin Liver Dis 1998, 2:781.
22. Plauth M., Cabré E., Rggio O., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
23. Gunsar F., Raimondo M.L., Jones S., et al. Nutrition status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006, 24:563-572.
24. Mathan L.K., Escott-Stump S. Krauses's food nutrition and diet therapy 2000, WB Saunders, Philadelphia.
25. Campillo B., Richardet J.P., Bories P.N. Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice. Gastroenterol Clin Biol 2005, 29:645-651.
26. Campillo B., Richardet J.P., Bories P.N. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol 2006, 30(10):1137-1143.
27. Delich P.C., Siepler J.K., Parker P. Liver disease. The A.S.P.E.N. nutrition support core curriculum: a case based approach-the adult patient 2007, 540-557. American Society for Parenteral and Enteral Nutrition, Silver Spring (MD). M.M. Gottschlich (Ed.).
28. Plauth M., Cabre E., Campillo B., et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 2009, 28:436-444.
29. Gundling F., Teich N., Strebel H.M., et al. Ernahrung beileberzirrhose. Med Klin 2007, 102:435-444.
30. Matos C., Porayko M.K., Francisco-Ziller N., et al. Nutrition and chronic liver disease. JClin Gastroenterol 2002, 35:391-397.
31. Nakaya Y., Okita K., Suzuki K., et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-120.
32. Moore K.P., Aithal G.P. Guidelines on the management of ascites in cirrhosis. Gut 2006, 55:1-12.
33. Salerno F., Guevara M., Bernardi M., et al. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 2010, 30:937-947.
34. Bresci G., Paris G., Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med 1993, 2:414-416.
35. Inoue E., Hori S., Narumi Y., et al. Portal-systemic encephalopathy; presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991, 179:551-555.
36. Amodio P., Bemeur C., Butterworth R., et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology 2013, 58:325-336.
37. Weisman Y. Vitamin D deficiency and insufficiency. Isr Med Assoc J 2013, 15:377-378.
38. Zhang C., Zhao L., Ma L., et al. Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis. Dig Dis Sci 2012, 57(1):182-188.
39. Rossi Fanelli F., Cangiano C., Capocaccia L., et al. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experience. Gut 1986, 27:111-115.
40. Holecek M., Simek J., Palicka V., et al. Effect of glucose and branched chain amino acids (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in a partially hepatectomized rat. JHepatol 1991, 13:14-20.
41. Alexander W.F., Spindel E., Harty R.F., et al. The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy. Am J Gastroenterol 1989, 84:91-96.
42. Lam V., Poon R.T. Role of branched chain amino acids in management of cirrhosis and hepatocellular carcinoma. Hepatol Res 2008, 38(Suppl 1):107-115.
43. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010, 26:482-490.
44. Holecek M. Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications. Nutrition 2013, 29(10):1186-1191.
45. Chadalavada R., Sappati Biyyani R.S., Maxwell J., et al. Nutrition in hepatic encephalopathy. Nutr Clin Pract 2010, 25:257-264.
46. James J.H., Ziparo V., Jeppsson B., et al. Hyperammonaemia, plasma aminoacid inbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979, 2:772-775.
47. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: double blind randomized trial. Gastroenterology 2003, 124:1792-1801.
48. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
49. Gunnarsdottir S.A., Sadik R., Shev S., et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003, 98(6):1362-1370.
50. Chandler Roland B., Garcia-Tsao G., Ciarleglio M.M., et al. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. JClin Gastroenterol 2013, [Epub head of print].
51. Shukla S., Shukla A., Mehboog S., et al. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011, 33:662-671.
52. Agrawal A., Sharma B.C., Sharma P., et al. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 2012, 107:1043-1050.
53. McGee R.G., Bakens A., Wiley K., et al. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011, (11). CD008716.